Literature DB >> 26188272

Long term follow up of two independent patients with Schinzel-Giedion carrying SETBP1 mutations.

Yvan Herenger1, Corinne Stoetzel2, Elise Schaefer1, Sophie Scheidecker1, Marie-Cécile Manière3, Valérie Pelletier4, Yves Alembik5, Dominique Christmann6, Jean-Michel Clavert7, Joelle Terzic7, Michel Fischbach7, Anne De Saint Martin7, Hélène Dollfus8.   

Abstract

Schinzel-Giedion syndrome (SGS, MIM #269150) is a rare syndrome characterized by severe intellectual disability, typical facial gestalt, hypertrichosis and multiple congenital malformations including skeletal, genitourinary, renal and cardiac abnormalities. The prognosis of SGS is very severe and death occurs generally within a few years after birth. In 2002, we reported 2 children with SGS with a follow-up of 3 years. They presented a very similar and particular phenotype associating distinctive facial gestalt, severe developmental delay, megacalycosis, progressive neurodegeneration, alacrimi, corneal hypoesthesia and deafness. Furthermore, temporal bone imaging revealed a tuning-fork malformation of the stapes. In 2010, Hoischen et al. identified in SGS patients pathogenic heterozygous de novo mutations in SETBP1. We sequenced SETBP1 in our patients and found the previously reported c.2608G>A (p.Gly870Ser) mutation in both children. Since 2002, one of our patients died at 6 years old and the other patient is still alive at 15 years old. Such a life expectancy has never been reported so far. We describe herein the follow up of the 2 children during 6 and 15 years respectively. This article gives further evidence of the implication of SETBP1 as the major gene of SGS, and reports the previously unseen natural evolution of the disease in a 15 years old patient.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Coraliform nephrolithiasis; Dental abnormalities; SETBP1; Schinzel–Giedion syndrome

Mesh:

Substances:

Year:  2015        PMID: 26188272     DOI: 10.1016/j.ejmg.2015.07.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  [Unusual facies with delayed development and multiple malformations in a 14-month-old boy].

Authors:  Tong Lu; Yi Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

Review 2.  Somatic SETBP1 mutations in myeloid neoplasms.

Authors:  Hideki Makishima
Journal:  Int J Hematol       Date:  2017-04-26       Impact factor: 2.490

Review 3.  Schinzel-Giedion syndrome: a novel case, review and revised diagnostic criteria.

Authors:  Wei-Liang Liu; Zhi-Xu He; Fang Li; Rong Ai; Hong-Wei Ma
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

4.  Common variation within the SETBP1 gene is associated with reading-related skills and patterns of functional neural activation.

Authors:  Meaghan V Perdue; Sara Mascheretti; Sergey A Kornilov; Kaja K Jasińska; Kayleigh Ryherd; W Einar Mencl; Stephen J Frost; Elena L Grigorenko; Kenneth R Pugh; Nicole Landi
Journal:  Neuropsychologia       Date:  2018-08-23       Impact factor: 3.139

5.  SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome.

Authors:  Federica Banfi; Alicia Rubio; Mattia Zaghi; Luca Massimino; Giulia Fagnocchi; Edoardo Bellini; Mirko Luoni; Cinzia Cancellieri; Anna Bagliani; Chiara Di Resta; Camilla Maffezzini; Angelo Ianielli; Maurizio Ferrari; Rocco Piazza; Luca Mologni; Vania Broccoli; Alessandro Sessa
Journal:  Nat Commun       Date:  2021-06-30       Impact factor: 14.919

6.  Common disease signatures from gene expression analysis in Huntington's disease human blood and brain.

Authors:  Eleni Mina; Willeke van Roon-Mom; Kristina Hettne; Erik van Zwet; Jelle Goeman; Christian Neri; Peter A C 't Hoen; Barend Mons; Marco Roos
Journal:  Orphanet J Rare Dis       Date:  2016-08-01       Impact factor: 4.123

7.  Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.

Authors:  Rocio Acuna-Hidalgo; Pelagia Deriziotis; Marloes Steehouwer; Christian Gilissen; Sarah A Graham; Sipko van Dam; Julie Hoover-Fong; Aida B Telegrafi; Anne Destree; Robert Smigiel; Lindsday A Lambie; Hülya Kayserili; Umut Altunoglu; Elisabetta Lapi; Maria Luisa Uzielli; Mariana Aracena; Banu G Nur; Ercan Mihci; Lilia M A Moreira; Viviane Borges Ferreira; Dafne D G Horovitz; Katia M da Rocha; Aleksandra Jezela-Stanek; Alice S Brooks; Heiko Reutter; Julie S Cohen; Ali Fatemi; Martin Smitka; Theresa A Grebe; Nataliya Di Donato; Charu Deshpande; Anthony Vandersteen; Charles Marques Lourenço; Andreas Dufke; Eva Rossier; Gwenaelle Andre; Alessandra Baumer; Careni Spencer; Julie McGaughran; Lude Franke; Joris A Veltman; Bert B A De Vries; Albert Schinzel; Simon E Fisher; Alexander Hoischen; Bregje W van Bon
Journal:  PLoS Genet       Date:  2017-03-27       Impact factor: 5.917

8.  Schinzel-Giedion Syndrome with Congenital Megacalycosis in a Turkish Patient: Report of SETBP1 Mutation and Literature Review of the Clinical Features.

Authors:  Ozgul Bulut; Zeynep Ince; Umut Altunoglu; Sukran Yildirim; Asuman Coban
Journal:  Case Rep Genet       Date:  2017-12-03

Review 9.  SETBP1 dysregulation in congenital disorders and myeloid neoplasms.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Antonella Zagaria; Luisa Anelli; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2017-04-19

10.  Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.

Authors:  Holly A F Stessman; Bo Xiong; Bradley P Coe; Tianyun Wang; Kendra Hoekzema; Michaela Fenckova; Malin Kvarnung; Jennifer Gerdts; Sandy Trinh; Nele Cosemans; Laura Vives; Janice Lin; Tychele N Turner; Gijs Santen; Claudia Ruivenkamp; Marjolein Kriek; Arie van Haeringen; Emmelien Aten; Kathryn Friend; Jan Liebelt; Christopher Barnett; Eric Haan; Marie Shaw; Jozef Gecz; Britt-Marie Anderlid; Ann Nordgren; Anna Lindstrand; Charles Schwartz; R Frank Kooy; Geert Vandeweyer; Celine Helsmoortel; Corrado Romano; Antonino Alberti; Mirella Vinci; Emanuela Avola; Stefania Giusto; Eric Courchesne; Tiziano Pramparo; Karen Pierce; Srinivasa Nalabolu; David G Amaral; Ingrid E Scheffer; Martin B Delatycki; Paul J Lockhart; Fereydoun Hormozdiari; Benjamin Harich; Anna Castells-Nobau; Kun Xia; Hilde Peeters; Magnus Nordenskjöld; Annette Schenck; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2017-02-13       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.